,,ii #aahth ,,congress #ast ,session ,s4 #fjf ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,march #a1 #bjbc,mr4 ,manchin 7for himself and ,mr4 ,braun7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to require the ,food and ,drug ,administration to revoke the approval of one opioid pain medication for each new opioid pain medication approved4 #a4 ,short title ,this ,act may be cited as the ,protecting ,americans from ,dangerous ,opioids ,act4 #b4 ,findings ,congress finds as follows3 7#a7 ,drug overdoses killed more than #ajg1jjj people in the ,united ,states in #bjba4 ,nearly two-thirds of all drug overdose deaths involved a prescription opioid or synthetic opioid4 7#b7 ,according to the ,national ,institute on ,drug ,abuse1 #hj percent of new heroin users abused prescription opioids before moving to heroin4 7#c7 ,the ,united ,states makes up only #d4be percent of the world's population1 but consumes #hj percent of its opioid pain medications4 7#d7 ,in #bjbj1 health care providers in the ,united ,states wrote nearly #adc1jjj1jjj prescriptions for painkillers1 which is #dc prescriptions per #ajj people4 7#e7 ,the amount of prescription opioids sold in the ,united ,states has increased without a reported increase in pain4 ,at the same time1 overdose deaths involving opioids have quadrupled since #aiii1 with more than #icb1jjj people having died from a drug overdose4 7#f7 ,although overdose death rates are beginning to see a slow decline1 over #ajf1jjj people are predicted to have died of drug overdose in #bjbb4 #c4 ,requirement to revoke approval 7a7 ,in general ,notwithstanding any other provision of law1 if the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary7 approves an application under subsection 7b7 or 7j7 of section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 for an opioid drug1 the ,secretary shall revoke the approval of another opioid drug previously approved under subsection 7c7 or 7j7 of such section #eje4 7b7 ,considerations ,in determining the drug for which the ,secretary will revoke approval pursuant to subsection 7a71 the ,secretary shall-- 7#a7 prioritize revocation of non-abuse deterrent formulations of opioid drugs2 and 7#b7 consider the public health impact of the opioid drug being on the market4